Skip to main content
Educational use only — not medical advice

Research library

AOD-9604 benefits

From the PeptideBase research library. Educational only — not medical advice.

Studied effects

  • selective fat tissue lipolysis via GH C-terminal fragment mechanism
  • adipose metabolism stimulation without IGF-1 elevation
  • originally developed to isolate GH lipolytic effect from growth effects
  • subcutaneous injection — reconstitution with bacteriostatic water required

Mechanism

AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.